The prophylactic and therapeutic effects of cholinolytics on perfluoroisobutylene inhalation induced acute lung injury

Journal of Occupational Health

Volumn 47, Issue 4, 2005, Pages 277-285

  Zhang, Tianhong ^a   Zhang, Xigang ^b   Shao, Zhihua ^c   Ding, Rigao ^a   Yang, Shunjiang ^c   Ruan, Jinxiu ^a   Sun, Xiaohong ^a   Xu, Jin ^c   Huang, Chunqian ^a   Hu, Zuliang ^c   Zhang, Xianchang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Beijing 307 Hospital   (China)

^c Quhua Group Corporation   (China)

Author keywords

3 Quinuclidinyl Benzilate (QNB); Acute lung injury (ALI); Anisodamine; Cholinolytics; Perfluoroisobutylene (PFIB)

Indexed keywords

ANISODAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ISOBUTYLENE; MYELOPEROXIDASE; PERFLUORO COMPOUND; QUINUCLIDINYL BENZILATE; THIOL DERIVATIVE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; LUNG; LUNG LAVAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PROPHYLAXIS; RAT; SHEAR RATE; TOXICITY; ULTRASTRUCTURE;

ANIMALS; BODY WEIGHT; CHINA; CHOLINERGIC ANTAGONISTS; FLUOROCARBONS; INHALATION EXPOSURE; LUNG; MALE; MICE; OCCUPATIONAL EXPOSURE; ORGAN SIZE; QUINUCLIDINYL BENZILATE; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT; SOLANACEOUS ALKALOIDS;

ANIMALIA;

EID: 25444492825     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.47.277     Document Type: Article

References (38)

1. G Oberdorster, J Ferin, J Gelein, R Finkelstein and R Baggs: Effects of PTFE Fumes in the Respiratory Tract: A Particle Effect? Aerospace Medical Association 65th Annual Scientific Meeting 538, A52 (1994)
2. ID Makulova: Clinical picture of acute poisoning with perfluorobutylene. Gig Tr Prof Zabol 9, 20-23 (1965)
3. JR Brainard, SA Kinkead, EM Kober, DM Staver and BE Lehnert: Potential involvement of HF in perfluoroisobutylene-induced lung injury. Toxicologist 12, 843-851(1992)
4. J Patocka and J Bajgar: Toxicology of Perfluoroisobutene. ASA Newsletter 22, 69 (1998)
5. CM Arroyo: The Chemistry of Perfluoroisobutylene (PFIB) with Nitrone and Nitroso Spin Traps: an EPR/Spin Trapping Study. Chem Biol Interact 105, 119-129 (1997)
6. AF Lailey, L Hill, IW Lawston, D Stanton and DG Upshall: Protection by cysteine esters against chemically induced pulmonary edema. Biochem Pharmacol 42(Suppl), S47-S54 (1991)
7. O Lesur, Y Berthiaume, G Blaise, P Damas, E Deland, JG Guimond and RP Michel: Acute respiratory distress syndrome: 30 years later. Can Respir J 6, 71-86 (1999)
8. BE Lehnert, D Archuleta, LR Gurley, W Session, MJ Behr, NM Lehnert and DM Stavert: Exercise Potentiation of Lung Injury Following Inhalation of a Pneumoedematogenic Gas: Perfluoroisobutylene. Exp Lung Res 21, 331-350 (1995)
9. WF Diller: The Methenamine Misunderstanding in the Therapy of Phosgene Poisoning. Arch Toxicol 46, 199-206 (1980)
10. LW Smith, RJ Gardner and GL Kennedy: Short-term inhalation toxicity of perfluoroisobutylene. Drug Chem Toxicol 5, 295-303 (1982)
11. WF Diller: Medical Phosgene Problems and Their Possible Solution. J Occup Med 20, 189-193 (1978)
12. RFR Brown and P Rice: Electron microscopy of rat lung following a single acute exposure to perfluoroisobutylene (PFIB). A sequential study of the first 24 hours following exposure. Int J Exp Path 72, 437-450 (1991)
13. LR Gurley, JS Buchanan, JE London, DM Stavert and BE Lehnert: High-performance capillary electrophoresis of proteins from the fluid lining of the lungs of rats exposed to perfluoroisobutylene. J Chromatography 559, 411-429 (1991)
14. WF Diller: Pathogenesis of Phosgene Poisoning. Toxicol Ind Health 1, 7-15 (1985)
15. H Wang, R Ding, J Ruan, B Yuan, X Sun, X Zhang, S Yu and W Qu: Perfluoroisobutylene-Induced Acute Lung Injury and Mortality are Heralded by Neutrophil Sequestration and Accumulation. J Occup Health 43, 331-338 (2001)
16. J Hamacher, R Lucas, HR Lijnen, S Buschke, Y Dunant, A Wendel, GE Grau, PM Suter and B Ricou: Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 166, 651-656 (2002)
17. CA Dinarello and N Savage: Interleukin-1 and its receptor. CRC Crit Rev Immunol 9, 1-20 (1989)
18. A Takala, I Jousela, O Takkunen, H Kautiainen, SE Jansson, A Orpana, SL Karonen and H Repo: A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock 17, 252-257 (2002)
19. T Nagase, N Uozumi, T Aoki-Nagase, K Terawaki, S Ishii, T Tomita, H Yamamoto, K Hashizume, Y Ouchi and T Shimizu: A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 284: L720-L726 (2003)
20. P Agouridakis, D Kyriakou, MG Alexandrakis, A Prekates, K Perisinakis, N Karkavitsas and D Bouros: The predictive role of serum and broncho alveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 3, 25 (2002)
21. LN Wilson, JD Pierce and RL Clancy: Reactive oxygen species in acute respiratory distress syndrome. Heart Lung 30, 370-375 (2001)
22. J Lanchou, M Corbel, M Tanguy, N Germain, E Boichot, N Theret, B Clement, V Lagente and Y Malledant: Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 31, 536-542 (2003)
23. TJ Moraes, CW Chow and GP Downey: Proteases and lung injury. Crit Care Med 31(4 Suppl), S189-S194 (2003)
24. M Bhatia and S Moochhala: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202, 145-156 (2004)
25. LM Colletti, GD Burtch, DG Remick, SL Kunkel, RM Strieter, KS Guice, KT Oldham and DA Campbell: The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49, 268-272 (1990)
26. K Byrne, PD Carey, TD Sielaff, JK Jenkins, CR Blocher, KR Cooper, AA Fowler and HJ Sugerman: Ibuprofen prevents deterioration in static transpulmonary compliance and transalveolar protein flux in septic porcine acute lung injury. J Trauma 31, 155-164 (1991)
27. T Nakamura and Y Ogawa: Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury induced by the intratracheal instillation of endotoxin in piglets. Biol Neonate 80, 163-168 (2001)
28. DE Carney, UG McCann, HJ Schiller, LA Gatto, J Steinberg, AL Picone and GF Nieman: Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res 99, 245-252 (2001)
29. S Zhang, AM Chang, CF Li, ZJ Li, ZJ Yin, X Zhao and SL Liang: Mechanism of the therapeutic effect of anisodamine in disseminated intravascular coagulation: study of platelet adhesion and aggregation, malondialdehyde, thromboxane B2, 6-keto-prostaglandin F1 alpha, and microcirculation. Exp Hematol 15, 65-71 (1987)
30. CQ Li, ZH Shao and YL Jing: Influence of anisodamine (654-2) on plasma levels of lipid peroxides in rabbits with SAO shock. Chinese J Pathophysiol 5, 547 (1989)
31. S Dai, J Cheng, R Sun, J Duan, Q Yuan, Y Sun, Y Yan and Q Xue: Hemodynamic and nonhemodynamic mechanisms of experimental pulmonary edema in rats and the effects of anisodamine and tetramethylpyrazine- estimation of blood gas analysis, RBC superoxide dismutase and prostaglandin E2 in plasma and bronchoalveolar lavage (Part 3). Chin Med Sci J 8, 210-214 (1993)
32. Q Huang, W Dai, Y Jie and G Yu: Protective effect of anisodamine on respiratory function after severe brain injury. Chin J Traumatol 5, 352-354 (2002)
33. J Chai, H Yang, Z Sheng, Z Guo, L Diao, C Shen, F Li, X Jia, L Li, M Xu, L He, D Hao and Y Yu: Anisodamine in prevention and treatment of sepsis of severely burned patients. Zhonghua Wai Ke Za Zhi 38, 686-689 (2000)
34. OH Lowry, NJ Rosebrogh, AL Farr and RJ Randall: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275 (1951)
35. BO Anderson, JM Brown, PF Shanley, DD Bensard and AH Harken: Marginating neutrophils are reversibly adherent to normal lung endothelium. Surgery 109, 51-61 (1991)
36. J Sedlak and RH Lindsay: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25, 192-205 (1968)
37. MA Matthay, GA Zimmerman, C Esmon, J Bhattacharya, B Coller, CM Doerschuk, J Floros, MA Gimbrone, E Hoffman, RD Hubmayr, M Leppert, S Matalon, R Munford, P Parsons, AS Slutsky, KJ Tracey, P Ward, DB Gail and AL Harabin: Future research directions in acute lung injury. Am J Respir Crit Care Med 167, 1027-1035 (2003)
38. Zajtchuk R eds. Textbook of military medicine series: medical aspects of chemical and biological warfare. Washington, D.C.: Office of the Surgeon General, Department of the Army, 1997: 287-305.